Skip to content
healthcare.dev

PREZISTA

NDC 59676-565, darunavir, suspension, from Janssen Products LP.

Product NDC
59676-565
Status
Listed
Labeler
Janssen Products LP
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202895
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59676-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARUNAVIR ETHANOLATE100 mg/mL

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]

Package NDCNDC-11Package
59676-565-01596760565011 BOTTLE, GLASS in 1 CARTON (59676-565-01) / 200 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/814301f9-c990-46a5-b481-2879a521a16f

Use it

Look up 59676-565 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59676-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59676-565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.